Pricing Log in Create free account

Lexicon Pharmaceuticals, Inc. (LXRX) vs Obsidian Therapeutics, Inc (OBX)

Lexicon Pharmaceuticals, Inc. and Obsidian Therapeutics, Inc are both Biotechnology companies. Lexicon Pharmaceuticals, Inc. and Obsidian Therapeutics, Inc are of similar size ($832.6M and $795.6M). Across the 6 metrics below, Obsidian Therapeutics, Inc leads on 4 and Lexicon Pharmaceuticals, Inc. on 2.

Valuation

Metric LXRX OBX Biotechnology median
P/E n/m — 11.58
P/S 21.82 n/m 9.61
P/B 5.13 n/m 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 18.53 n/m 9.43
Earnings yield (7.54%) — (32.28%)
Free cash flow yield (5.98%) 0.00% (22.27%)

Profitability

Metric LXRX OBX Biotechnology median
Gross margin 98.89% — 68.81%
Operating margin (147.42%) — 0.00%
Net margin (161.80%) — 0.00%
Free cash flow margin (127.76%) — 0.00%
Return on equity (43.91%) — (50.30%)
Return on assets (27.84%) — (45.47%)
Return on invested capital (109.13%) 0.00% 0.00%

Growth

Metric LXRX OBX Biotechnology median
Revenue growth (TTM) (45.62%) — 6.78%
EPS growth (last fiscal year) 77.78% (11.60%) 29.88%
Revenue growth, 5-year CAGR 15.72% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric LXRX OBX Biotechnology median
Debt to equity 0.32 0.00 0.00
Current ratio 10.63 4.21 4.74
Net debt to EBITDA 0.91 0.77 1.01

Dividend

Metric LXRX OBX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric LXRX OBX Biotechnology median
Market cap 832.59m 795.63m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack